SpbR controls lipoteichoic acid length by directly inhibiting signal peptidase SpsB in Staphylococcus aureus
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2426464122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Youngseon Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115. Hauptthemen laut MEDLINE: Teichoic Acids, Staphylococcus aureus, Lipopolysaccharides, Bacterial Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Staphylococcus aureus is a Gram-positive pathogen that causes life-threatening infections. Its cell envelope contains anionic polymers called teichoic acids that are required for cell viability. Teichoic acids come in two forms and are made by different biosynthetic pathways. One form, lipoteichoic acid (LTA), is anchored in the cell membrane; the other form, wall teichoic acid (WTA), is covalently linked to the peptidoglycan cell wall. Although the LTA and WTA biosynthetic pathways have been characterized, regulation of teichoic acid production is not well understood. Here, we identified SpbR ( SAOUHSC_00965 ), a polytopic membrane protein similar to a eukaryotic CAAX protease, as a factor that controls LTA levels in S. aureus cells. We show that loss of SpbR results in short LTAs and a synthetically sick phenotype when WTA biosynthesis is prevented, whereas overexpressing SpbR results in elongated LTAs. Mechanistically, we find that SpbR physically associates with the type I signal peptidase SpsB, which cleaves LtaS, the polymerase that assembles LTA on the extracellular side of the membrane, and we show that this physical interaction inhibits SpsB cleavage of LtaS both in vivo and in vitro. Although the phenotypes investigated here are dominated by SpbR’s effects on LtaS, it also inhibits cleavage of other SpsB substrates. Based on its role in regulating the activity of SpsB, we named this factor SpbR ( S ignal p eptidase b R egulator).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
- Section of Molecular Microbiology and Centre for Bacterial Resistance Biology, Department of Infectious Disease, Imperial College London, London SW7 2AZ, United Kingdom.
ORCID-Profile: Youngseon Park, Tyler A Sisley, Madeleine C Stone, Rebecca M Corrigan, Angelika Gründling, Suzanne Walker
Förderung
- NIAID NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Park, Y., Sisley, T. A., Stone, M. C., Corrigan, R. M., Vickery, C. R., Gründling, A., & Walker, S. (2025). SpbR controls lipoteichoic acid length by directly inhibiting signal peptidase SpsB in Staphylococcus aureus. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2426464122
Vancouver
Park Y, Sisley TA, Stone MC, Corrigan RM, Vickery CR, Gründling A, et al. SpbR controls lipoteichoic acid length by directly inhibiting signal peptidase SpsB in Staphylococcus aureus. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2426464122
BibTeX
@article{Park2025,
author = {Park, Youngseon and Sisley, Tyler A and Stone, Madeleine C and Corrigan, Rebecca M and Vickery, Christopher R and Gründling, Angelika and Walker, Suzanne},
title = {SpbR controls lipoteichoic acid length by directly inhibiting signal peptidase SpsB in Staphylococcus aureus},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2426464122}
}
EUVIMED